Corbus Pharmaceuticals

Corbus is a biotechnology company that develops and commercializes novel therapeutics for the treatments of inflammatory and fibrotic diseases. Read more

Yuval Cohen's photo - Co-Founder & CEO of Corbus Pharmaceuticals

Co-Founder & CEO

Yuval Cohen

CEO Approval Rating

89/100

Founded:

2009

Status:

PublicIndependent CompanyNASDAQCRBP

CORBUS PHARMACEUTICALS TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

EHP is seen as one of Corbus Pharmaceuticals's biggest rivals. EHP was founded in 2017 in San Diego, California. EHP operates in the Health Care Supplies industry. EHP generates $ less revenue than Corbus Pharmaceuticals.

Galapagos NV is one of Corbus Pharmaceuticals's top competitors. Galapagos NV was founded in 1999, and its headquarters is in Mechelen, Other. Like Corbus Pharmaceuticals, Galapagos NV also competes in the Pharmaceuticals space. Galapagos NV has 1,227 more employees than Corbus Pharmaceuticals.

Kadmon is one of Corbus Pharmaceuticals's top rivals. Kadmon was founded in 2009, and is headquartered in New York, New York. Like Corbus Pharmaceuticals, Kadmon also works within the Pharmaceuticals sector. Kadmon generates $707K less revenue vs. Corbus Pharmaceuticals.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Principia Biopharma, Inc. a competitor of Corbus Pharmaceuticals?

Corbus Pharmaceuticals Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$2.8M

Corbus Pharmaceuticals's revenue is the ranked 21th among it's top 10 competitors. The top 10 competitors average 181.2M. Over the last four quarters, Corbus Pharmaceuticals's revenue has grown by 126.2%. Specifically, in Q1 2021's revenue was $ < 1M; in Q4 2020, it was $ < 1M; in Q3 2020, it was $1.2M; in Q2 2020, Corbus Pharmaceuticals's revenue was $ < 1M.

Corbus Pharmaceuticals Acquisitions

No recent acquisitions found related to Corbus Pharmaceuticals

Corbus Pharmaceuticals Funding History

Since Corbus Pharmaceuticals was founded in 2009, it has participated in 6 rounds of funding. In total Corbus Pharmaceuticals has raised $93.9M. Corbus Pharmaceuticals' last funding round was on Jul 2020 for a total of $50.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Debt
Jul 2020
$50M

K2 HealthVentures

Private Placement
Feb 2017
$27.2M
-
Equity
Jun 2014
$10.3M
-
Equity
Apr 2014
$6.3M
-
Equity
Mar 2014
$19.8K
-

Since Corbus Pharmaceuticals was founded in 2009, it has participated in 6 rounds of funding. In total Corbus Pharmaceuticals has raised $93.9M. Corbus Pharmaceuticals' last funding round was on Jul 2020 for a total of $50.0M

Corbus Pharmaceuticals Investments

No recent investments found related to Corbus Pharmaceuticals

Corbus Pharmaceuticals News

April 20, 2021Markets Insider

Corbus Pharmaceuticals Announces Completion of Enrollment in NIH-Sponsored Phase 2 Study of Lenabasum for Treatment of Systemic Lupus Erythematosus (SLE)

First study to explore potential benefit of a cannabinoid receptor type 2 agonist in SLEStudy sponsor... See more »
March 30, 2021Markets Insider

Corbus Pharmaceuticals Reports Last Subject Visit in DETERMINE Phase 3 Study of Lenabasum for Treatment of Dermatomyositis

Topline data on schedule for Q2 2021Dermatomyositis is a rare and life-threatening autoimmune disease... See more »
March 15, 2021Markets Insider

Corbus Pharmaceuticals Reports Fourth Quarter and Year-End 2020 Financial Results

●Phase 3 study of lenabasum in dermatomyositis on schedule for topline data in Q2 2021 ●Company focus... See more »
March 9, 2021Markets Insider

Corbus Pharmaceuticals to Present at Two Upcoming Investor Conferences

Norwood, MA, March 09, 2021 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ... See more »
March 8, 2021Markets Insider

Corbus Pharmaceuticals to Report Fourth Quarter and Year-End 2020 Results on March 15, 2021

• Company to host conference call and webcast on Monday, March 15, 2021 at 8:30 a.m. ETNorwood, MA, M... See more »
February 2, 2021Benzinga

ROCE Insights For Corbus Pharmaceuticals

During Q3, Corbus Pharmaceuticals (NASDAQ:CRBP) brought in sales totaling $1.23 million. However, ear... See more »

Corbus Pharmaceuticals Press Releases

March 5, 2020StreetInsider

Corbus Pharmaceuticals to Report Fourth Quarter and Year-End 2019 Results on March 12, 2020

- Management to host conference call and webcast on Thursday, March 12 at 8:30 a.m. ET - Norwood, MA,... See more »
December 9, 2019GlobeNewswire

Corbus Pharmaceuticals to Host Expert Symposium on the Therapeutic Potential of Targeting the Endocannabinoid System

- Live video webcast on Friday, December 13, 2019 from 1:00 PM - 2:30 PM ET... See more »
May 29, 2019GlobalNewswire

Corbus Pharmaceuticals to Present at Two Upcoming Investor Conferences in June

Norwood, MA, May 29, 2019 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("... See more »
May 28, 2019GlobeNewswire

Corbus Pharmaceuticals Announces Presentation of Six Abstracts at EULAR 2019 Annual Meeting

Norwood, MA , May 28, 2019 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (... See more »
May 15, 2019GlobeNewswire

Corbus Pharmaceuticals to Present at Two Upcoming Investor Conferences in May

Norwood, MA, May 15, 2019 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("... See more »
May 9, 2019GlobalNewswire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Bridgepoint, Corbus, and NIO and Encourages Investors to Contact the Firm

NEW YORK, May 08, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that class a... See more »

Corbus Pharmaceuticals Videos

Social Media

Corbus Pharmaceuticals Headquarters

500 River Ridge Drive

Norwood, Massachusetts02062

617-963-0100

Driving Directions »

Trending Companies

Corbus Pharmaceuticals Summary

ABOUT

Overview

Corbus is a biotechnology company that develops and commercializes novel therapeutics for the treatments of inflammatory and fibrotic diseases. Corbus Pharmaceuticals was founded in 2009. Corbus Pharmaceuticals' headquarters is located in Norwood, Mas...

CEO

Corbus Pharmaceuticals's Co-Founder & CEO, Yuval Cohen, currently has an approval rating of 89%. Corbus Pharmaceuticals's primary competitors are EHP, Galapagos NV & Kadmon.

Frequently Asked Questions about Corbus Pharmaceuticals

  1. When was Corbus Pharmaceuticals founded?

    Corbus Pharmaceuticals was founded in 2009
  2. Who is Corbus Pharmaceuticals's CEO?

    Corbus Pharmaceuticals's CEO is Yuval Cohen
  3. How much revenue does Corbus Pharmaceuticals generate?

    Corbus Pharmaceuticals generates $2.8M in revenue
  4. How much funding does Corbus Pharmaceuticals have?

    Corbus Pharmaceuticals has historically raised $93.9M in funding
  1. Where is Corbus Pharmaceuticals's headquarters?

    Corbus Pharmaceuticals's headquarters is in Norwood Massachusetts, USA
  2. How many employees does Corbus Pharmaceuticals have?

    Corbus Pharmaceuticals has 77 employees
  3. What sector does Corbus Pharmaceuticals operate in?

    Corbus Pharmaceuticals is in Pharmaceuticals, Biotechnology
  4. Who are Corbus Pharmaceuticals's competitors?

    Corbus Pharmaceuticals's top competitors are EHP, Galapagos NV, Kadmon